Ignite Creation Date:
2024-05-05 @ 5:28 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00462761
Status:
COMPLETED
Last Update Posted:
2020-05-11
First Post:
2007-04-17
Brief Title:
A Phase I Study of AC220 in Patients With RelapsedRefractory Acute Myeloid Leukemia Regardless of FLT3 Status
Sponsor:
Daiichi Sankyo
Organization:
Daiichi Sankyo
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Acute Myeloid Leukemia |
| Leukemia |
| Myelodysplastic Syndrome |
| AML |
| MDS |
Keywords:
| Name | View |
|---|---|
| RTK | View |
| kinase | View |
| inhibitor | View |
| tyrosine | View |
| acute | View |
| FLT3 | View |
| AC220 | View |
| pharmacokinetic | View |
| pharmacokinetics | View |
| PK | View |
| pharmacodynamic | View |
| pharmacodynamics | View |
| mutations | View |
| PD | View |
| receptor | View |
| class III | View |
| relapsed | View |
| refractory | View |
| t821 | View |
| q22q22 | View |
| AML1ETO | View |
| t1616 | View |
| p13q22 | View |
| CBFbetaMYH11 | View |
| inv16 | View |
| p13q22 | View |
| 11q23 | View |
| dysplasia | View |
| myeloid | View |
| myelomonocytic | View |
| monoblastic | View |
| monocytic | View |
| erythroid | View |
| erythroleukemia | View |
| megakaryoblastic | View |
| basophilic | View |
| panmyelosis | View |
| myelofibrosis | View |